Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Schizophrenia

Free Subscription 19.10.2026 1 Biol Psychiatry 1 BMJ 2 Br J Psychiatry 1 Brain Res 4 Mol Psychiatry 2 Nature 2 PLoS Comput Biol 1 Psychiatry Res 1 Psychol Med 4 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Biol Psychiatry

1. SIMONS NW, Patel V, Li H, Iyer S, et al
   Development of a messenger RNA therapy for schizophrenia.
   Biol Psychiatry. 2026 Oct 12:S0006-3223(26)01589.
   PubMed         Abstract available
   
   

   
   BMJ

2. FURNEAUX R
   GLP-1s and schizophrenia: Drug is linked to lower need for acute care in patients with schizophrenia and type 2 diabetes, study suggests.
   BMJ. 2026;395:e101146.
   PubMed        
   
   

   
   Br J Psychiatry

3. HAUSSLER SM, Prata D, Kempton MJ, Bhavsar V, et al
   Genetic evidence for the psychosis continuum: polygenic score analysis.
   Br J Psychiatry. 2026 Oct 14:1-8. doi: 10.1192/bjp.2026.10795.
   PubMed         Abstract available
   
   
4. UVAIS NA
   Evaluating the ethics of advanced neurodiagnostics in psychosis: an Indian perspective.
   Br J Psychiatry. 2026 Oct 12:1-2. doi: 10.1192/bjp.2026.10803.
   PubMed        
   
   

   
   Brain Res

5. LIN Y, Wen G, Hu X, Hu R, et al
   Metformin alleviates neuronal injury in MK-801-Induced Schizophrenia-Like mice by inhibiting neuronal ferroptosis.
   Brain Res. 2026 Oct 13:150599. doi: 10.1016/j.brainres.2026.150599.
   PubMed         Abstract available
   
   

   
   Mol Psychiatry

6. EYLES D, Du Z, Cui X, Kesby JP, et al
   Correction: "Increasing dopamine synthesis capacity in the dorsal striatum and tonic acetylcholine: implications for the new muscarinic agents in the treatment of schizophrenia".
   Mol Psychiatry. 2026 Oct 12. doi: 10.1038/s41380-026-03923.
   PubMed        
   
   
7. BALLEM R, Andres-Camazon P, Jensen KM, Bajracharya P, et al
   Mapping the psychosis spectrum - imaging neurosubtypes from multiscale functional network connectivity.
   Mol Psychiatry. 2026 Oct 9. doi: 10.1038/s41380-026-03921.
   PubMed         Abstract available
   
   
8. HUANG S, Yang SM, Bellier L, Cheng D, et al
   Antipsychotic-like effects of TAAR1 agonists and D2 receptor blockers are mediated through distinct modulation of striatal neuronal dynamics.
   Mol Psychiatry. 2026;31:6559-6571.
   PubMed         Abstract available
   
   
9. QIN K, Zhu P, Chen X, Sang L, et al
   Transdiagnostic mapping of brain structural abnormalities and network-constrained gray matter atrophy patterns across affective and psychotic disorders.
   Mol Psychiatry. 2026;31:6317-6326.
   PubMed         Abstract available
   
   

   
   Nature

10. SHIH YT, Alipio JB, Klaft ZJ, Green N, et al
    Procognitive restoration of PV neuron plasticity in neurodevelopmental disorders.
    Nature. 2026;658:736-746.
    PubMed         Abstract available
    
    
11. JONES IR, Wang L, Kosicki M, Battle SL, et al
    3D epigenome of glial cell types in developing human cortex.
    Nature. 2026;658:795-804.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

12. BERA K, Fengler A, Boudewyn MA, Carter CS, et al
    Modeling decision dynamics disentangles working memory, cognitive control and reinforcement learning and reveals clinical differences.
    PLoS Comput Biol. 2026;22:e1014796.
    PubMed         Abstract available
    
    
13. SANCHEZ-CARBONELL M, Bolshakova S, Avila-Pagan JE, Sabir YA, et al
    Sparse neuronal C4 elevation induces network-wide transcriptomic and lipid-droplet remodeling in the cortical microenvironment.
    PLoS Comput Biol. 2026;22:e1014871.
    PubMed         Abstract available
    
    

    
    Psychiatry Res

14. JIN M, Wang H, Li H, Mao S, et al
    Peripheral blood miR-15b-5p and ABCC6 are candidate biomarkers of early antipsychotic treatment response in first-episode schizophrenia.
    Psychiatry Res. 2026;367:117491.
    PubMed         Abstract available
    
    

    
    Psychol Med

15. ZHAO S, Jin Q, Wang Z, Liu MY, et al
    Examinations of the heterogeneity in the structural brain connectome in schizophrenia.
    Psychol Med. 2026;56:e327.
    PubMed         Abstract available
    
    

    
    Schizophr Res

16. MA Z, Sheng Z, Wen L, Cai D, et al
    Reduced DTI-ALPS is associated with affected status rather than cumulative genetic and environmental risk in offspring of parents with schizophrenia.
    Schizophr Res. 2026;298:150-157.
    PubMed         Abstract available
    
    
17. DING Y, Han Y, Huang S, Shi X, et al
    Dynamic negative symptom networks following personalized iTBS in schizophrenia.
    Schizophr Res. 2026;298:140-149.
    PubMed         Abstract available
    
    
18. KAISER KA, Thompson JL, Butler PD, Ahmed AO, et al
    Effects of visual remediation on contour integration performance in schizophrenia spectrum disorders.
    Schizophr Res. 2026;298:166-174.
    PubMed         Abstract available
    
    
19. MITSUBAYASHI R, Tarutani S, Amano M, Furuya T, et al
    Exploring the "insight paradox" in Japanese inpatients with schizophrenia: A cluster analysis cross-sectional study based on insight and internalized stigma including comparisons of subjective outcomes.
    Schizophr Res. 2026;298:183-190.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum